Back to News
Market Impact: 0.5

LRCX Quantitative Stock Analysis

LRCXNDAQ
Company FundamentalsAnalyst InsightsTechnology & InnovationCorporate Earnings
LRCX Quantitative Stock Analysis

Validea's guru fundamental report indicates that LAM RESEARCH CORP (LRCX) receives a 100% rating based on their Patient Investor model, which is based on the investment strategy of Warren Buffett. The analysis highlights LRCX's strong fundamentals, including earnings predictability, debt service, return on equity, return on total capital, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return, suggesting the stock aligns well with Buffett's criteria for long-term, predictable profitability and reasonable valuation.

Analysis

Lam Research Corp (LRCX) has received a perfect 100% rating from Validea's Patient Investor model, an investment strategy based on the principles of Warren Buffett. This top score signifies strong interest, as the model seeks firms with long-term, predictable profitability, low debt, and reasonable valuations. LRCX, identified as a large-cap growth stock within the Semiconductors industry, successfully met all nine criteria evaluated by this specific strategy: Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, Free Cash Flow, Use of Retained Earnings, Share Repurchase, Initial Rate of Return, and Expected Return. The associated sentiment for LRCX is extremely positive, with a score of 0.9, reflecting a bullish tone based on this fundamental assessment. This comprehensive positive evaluation underscores the company's strong underlying fundamentals and favorable valuation from the perspective of this particular investment model.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

extremely positive

Sentiment Score

0.90

Ticker Sentiment

LRCX0.90
NDAQ0.00

Key Decisions for Investors

  • Investors employing a long-term, fundamentally-driven investment approach similar to Warren Buffett's should view Lam Research Corp's 100% rating under Validea's Patient Investor model as a strong positive signal.
  • The fact that LRCX passed all nine key financial health and valuation metrics in this model, including earnings predictability and return on equity, warrants close consideration for portfolios seeking quality companies in the semiconductor sector.
  • Considering the extremely positive sentiment and LRCX's strong alignment with criteria emphasizing predictable profitability and low debt, further due diligence is merited to assess if it aligns with individual investment objectives and risk tolerance for a long-term holding.